argus

Sun Pharmaceutical Industries Ltd.

NSE: SUNPHARMAINE044A01036₹4,63,169 Cr

Timeline

Time (IST)TypeMEventSrc
14 Jan, 02:41 pm—…Sun Pharmaceutical Industries Ltd - 524715 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011bse
26 Dec, 02:51 pm—…Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
26 Dec, 02:48 pm—…Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentationnse
18 Dec, 08:27 am—…Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 US FDA determines Baska facility inspection classification as OAInse
02 Dec, 11:08 pm—…Sun Pharmaceutical Industries Limited has informed the Exchange about Approval of proposal for Greenfield Projectnse
02 Dec, 11:08 pm—…Sun Pharmaceutical Industries Ltd - 524715 - Intimation Under Regulation 30 - Approval Of Proposal For Greenfield Projectbse
01 Dec, 09:11 am—…Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
01 Dec, 09:08 am—…Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated December 01, 2025, titled "Sun Pharma introduces its global innovative drug, Ilumya® inIndia for treatment of moderate-to-severe Plaque Psoriasis".nse
26 Nov, 10:29 am—…Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
26 Nov, 08:54 am—…Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated November 26, 2025nse
22 Nov, 02:11 pm—…Sun Pharmaceutical Industries Limited has informed the Exchange about Effective date of Composite Scheme of Arrangementnse
22 Nov, 01:46 pm—…Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Scheme of Arrangementbse
17 Nov, 04:05 pm—…Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
17 Nov, 04:02 pm—…Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated November 17, 2025, titled "AstraZeneca Pharma India Limited and Sun Pharma partner to help patients living with Hyperkalaemia in India".nse
12 Nov, 04:04 pm—…Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
12 Nov, 04:04 pm—…Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press releasense
12 Nov, 09:18 am—…Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated November 12, 2025, titled "Philogen provides update on Fibromun clinical study developments".nse
12 Nov, 08:58 am—…Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
11 Nov, 04:00 pm—…Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
11 Nov, 03:56 pm—…Sun Pharmaceutical Industries Limited has informed the Exchange about Transcriptnse
05 Nov, 08:32 pm—…Sun Pharmaceutical Industries Limited has informed the Exchange about Link of Recordingnse
05 Nov, 08:30 pm—…Sun Pharmaceutical Industries Ltd - 524715 - Investor Call Audio Recordingbse
05 Nov, 04:22 pm—…Sun Pharmaceutical Industries Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company.nse
05 Nov, 04:21 pm—…Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Associationbse
05 Nov, 04:05 pm—…Sun Pharmaceutical Industries Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.nse
05 Nov, 04:05 pm—…Sun Pharmaceutical Industries Ltd - 524715 - Financial Results For The Quarter And Half-Year Ended 30 September 2025bse
14 Oct, 05:51 pm—…Sun Pharmaceutical Industries Ltd - 524715 - Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter And Half Year Ended 30 September 2025.bse
14 Oct, 04:48 pm—…Sun Pharmaceutical Industries Limited has informed the Exchange regarding 'ESG Overview for FY2024-25'.nse
08 Oct, 08:23 pm—…Sun Pharmaceutical Industries Limited has informed the Exchange about Approval of Composite Scheme of Arrangement by NCLTnse
08 Oct, 08:23 pm—…Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Scheme of Arrangementbse
10 Sept, 11:40 am—…Sun Pharmaceutical Industries Ltd - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.bse
09 Sept, 08:26 pm—…Sun Pharmaceutical Industries Limited has informed the Exchange about update on US FDA Inspection at Sun Pharma Halol Facilitynse
01 Sept, 05:34 pm—…Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
01 Sept, 05:28 pm—…Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentationnse